この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2003/3/171 分で読めます
Determination of Regulatory Review Period for Purposes of Patent Extension; VITREON; Amendment
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending its determination regarding the regulatory review period for purposes of patent extension for VITREON that appeared in the Federal Register of December 17, 1998 (63 FR 69633). FDA is amending the document because the agency agrees with the information provided in a request from the applicant for revision of the regulatory review period.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →